Curcumin in gastric cancer treatment: A commentary on mechanistic insights and future directions

Area of Science:

• Pharmacology
• Oncology
• Computational Biology

Background:

• Gastric cancer (GC) remains a significant global health challenge.
• Curcumin, a compound from turmeric, has demonstrated anti-cancer properties.
• Identifying molecular targets is crucial for developing effective GC therapies.

Purpose of the Study:

• To investigate the therapeutic potential of curcumin for gastric cancer (GC).
• To identify key genes and pathways targeted by curcumin in GC using network pharmacology.

Main Methods:

• Network pharmacology to identify curcumin-related genes and their overlap with GC targets.
• Molecular docking to assess the binding affinity of curcumin to key genes.
• In vitro experiments using BGC-823 cells to evaluate curcumin's effect on cell growth and proliferation.

Main Results:

• Identified 48 curcumin-related genes, with 31 overlapping GC targets.
• Key genes such as ESR1, EGFR, and CYP3A4 were associated with poor GC survival.
• Curcumin demonstrated strong binding affinity to these target genes and inhibited BGC-823 cell growth in vitro.

Conclusions:

• Curcumin exhibits therapeutic potential for gastric cancer through multi-target and multi-pathway mechanisms.
• The study highlights specific genes as potential therapeutic targets for curcumin in GC treatment.
• Further research into curcumin-based therapies for GC is warranted.